APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma for Fractionation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plasma for Fractionation Market Analysis and Forecast 2026-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchPlasma for Fractionation Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma for Fractionation Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Plasma for Fractionation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma for Fractionation Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma for Fractionation Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Plasma for Fractionation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plasma for Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plasma for Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plasma for Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plasma for Fractionation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plasma for Fractionation include Biotest, BPL, CBPO, CSL, Grifols, Kedrion, LFB Group, Octapharma and Hualan Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plasma for Fractionation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plasma for Fractionation, also provides the revenue of main regions and countries. Of the upcoming market potential for Plasma for Fractionation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plasma for Fractionation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma for Fractionation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plasma for Fractionation revenue, projected growth trends, production technology, application and end-user industry.

Plasma for Fractionation Segment by Company

Biotest

BPL

CBPO

CSL

Grifols

Kedrion

LFB Group

Octapharma

Hualan Bio

RAAS

Takeda

Plasma for Fractionation Segment by Type

Recovered Plasma

Source Plasma

Plasma for Fractionation Segment by Application

Albumin

Immune Globulin

Coagulation Factor

Others

Plasma for Fractionation Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma for Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma for Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma for Fractionation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plasma for Fractionation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plasma for Fractionation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma for Fractionation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plasma for Fractionation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recovered Plasma Major Player Table 3. Source Plasma Major Player Table 4. Global Plasma for Fractionation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Albumin Major Player Table 6. Immune Globulin Major Player Table 7. Coagulation Factor Major Player Table 8. Others Major Player Table 9. Plasma for Fractionation Industry Trends Table 10. Plasma for Fractionation Industry Drivers Table 11. Plasma for Fractionation Industry Opportunities and Challenges Table 12. Plasma for Fractionation Industry Restraints Table 13. Global Plasma for Fractionation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Plasma for Fractionation Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Plasma for Fractionation Market Share by Region (2021-2026) Table 16. Global Plasma for Fractionation Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Plasma for Fractionation Market Share by Region (2027-2032) Table 18. Global Plasma for Fractionation Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Plasma for Fractionation Revenue Market Share by Players (2021-2026) Table 20. Global Plasma for Fractionation Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Plasma for Fractionation Key Players Headquarters & Area Served Table 22. Global Plasma for Fractionation Players, Product Type & Application Table 23. Global Plasma for Fractionation Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Plasma for Fractionation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Plasma for Fractionation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plasma for Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Plasma for Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Plasma for Fractionation Revenue Market Share by Type (2021-2026) Table 30. Global Plasma for Fractionation Revenue Market Share by Type (2027-2032) Table 31. Global Plasma for Fractionation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plasma for Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Plasma for Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Plasma for Fractionation Revenue Market Share by Application (2021-2026) Table 35. Global Plasma for Fractionation Revenue Market Share by Application (2027-2032) Table 36. Biotest Company Information Table 37. Biotest Business Overview Table 38. Biotest Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Biotest Plasma for Fractionation Product Portfolio Table 40. Biotest Recent Development Table 41. BPL Company Information Table 42. BPL Business Overview Table 43. BPL Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. BPL Plasma for Fractionation Product Portfolio Table 45. BPL Recent Development Table 46. CBPO Company Information Table 47. CBPO Business Overview Table 48. CBPO Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. CBPO Plasma for Fractionation Product Portfolio Table 50. CBPO Recent Development Table 51. CSL Company Information Table 52. CSL Business Overview Table 53. CSL Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CSL Plasma for Fractionation Product Portfolio Table 55. CSL Recent Development Table 56. Grifols Company Information Table 57. Grifols Business Overview Table 58. Grifols Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Grifols Plasma for Fractionation Product Portfolio Table 60. Grifols Recent Development Table 61. Kedrion Company Information Table 62. Kedrion Business Overview Table 63. Kedrion Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Kedrion Plasma for Fractionation Product Portfolio Table 65. Kedrion Recent Development Table 66. LFB Group Company Information Table 67. LFB Group Business Overview Table 68. LFB Group Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. LFB Group Plasma for Fractionation Product Portfolio Table 70. LFB Group Recent Development Table 71. Octapharma Company Information Table 72. Octapharma Business Overview Table 73. Octapharma Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Octapharma Plasma for Fractionation Product Portfolio Table 75. Octapharma Recent Development Table 76. Hualan Bio Company Information Table 77. Hualan Bio Business Overview Table 78. Hualan Bio Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Hualan Bio Plasma for Fractionation Product Portfolio Table 80. Hualan Bio Recent Development Table 81. RAAS Company Information Table 82. RAAS Business Overview Table 83. RAAS Plasma for Fractionation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. RAAS Plasma for Fractionation Product Portfolio Table 85. RAAS Recent Development Table 86. Takeda Company Information Table 87. Takeda Business Overview Table 88. Takeda Plasma for Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Takeda Plasma for Fractionation Product Portfolio Table 90. Takeda Recent Development Table 91. North America Plasma for Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Plasma for Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Plasma for Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Plasma for Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Plasma for Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Plasma for Fractionation Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Plasma for Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Plasma for Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Plasma for Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Plasma for Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Plasma for Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Plasma for Fractionation Revenue by Country (US$ Million) & (2027-2032) Table 105. China Plasma for Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 106. China Plasma for Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 107. China Plasma for Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 108. China Plasma for Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Plasma for Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Plasma for Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Plasma for Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Plasma for Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Plasma for Fractionation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Plasma for Fractionation Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Plasma for Fractionation Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Plasma for Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Plasma for Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Plasma for Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Plasma for Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Plasma for Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Plasma for Fractionation Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Plasma for Fractionation Image Figure 2. Global Plasma for Fractionation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma for Fractionation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recovered Plasma Image Figure 5. Source Plasma Image Figure 6. Global Plasma for Fractionation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Plasma for Fractionation Market Size Share 2021 VS 2025 VS 2032 Figure 8. Albumin Image Figure 9. Immune Globulin Image Figure 10. Coagulation Factor Image Figure 11. Others Image Figure 12. Global Plasma for Fractionation Market Size (US$ Million) & (2021-2032) Figure 13. Global Plasma for Fractionation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Plasma for Fractionation Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Plasma for Fractionation Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Plasma for Fractionation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plasma for Fractionation Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Plasma for Fractionation Revenue Market Share by Type (2021-2032) Figure 20. Global Plasma for Fractionation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Plasma for Fractionation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Plasma for Fractionation Revenue Market Share by Application (2021-2032) Figure 23. North America Plasma for Fractionation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Plasma for Fractionation Revenue Share by Type (2021-2032) Figure 25. North America Plasma for Fractionation Revenue Share by Application (2021-2032) Figure 26. North America Plasma for Fractionation Revenue Share by Country (2021-2032) Figure 27. United States Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Plasma for Fractionation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Plasma for Fractionation Revenue Share by Type (2021-2032) Figure 32. Europe Plasma for Fractionation Revenue Share by Application (2021-2032) Figure 33. Europe Plasma for Fractionation Revenue Share by Country (2021-2032) Figure 34. Germany Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Plasma for Fractionation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Plasma for Fractionation Revenue Share by Type (2021-2032) Figure 44. China Plasma for Fractionation Revenue Share by Application (2021-2032) Figure 45. Asia Plasma for Fractionation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Plasma for Fractionation Revenue Share by Type (2021-2032) Figure 47. Asia Plasma for Fractionation Revenue Share by Application (2021-2032) Figure 48. Asia Plasma for Fractionation Revenue Share by Region (2021-2032) Figure 49. Japan Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Plasma for Fractionation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Plasma for Fractionation Revenue Share by Type (2021-2032) Figure 57. SAMEA Plasma for Fractionation Revenue Share by Application (2021-2032) Figure 58. SAMEA Plasma for Fractionation Revenue Share by Country (2021-2032) Figure 59. Brazil Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Plasma for Fractionation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Recovered Plasma
  • Source Plasma
Applications
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Others
Companies covered
  • Biotest
  • BPL
  • CBPO
  • CSL
  • Grifols
  • Kedrion
  • LFB Group
  • Octapharma
  • Hualan Bio
  • RAAS
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plasma for Fractionation Market by Type
  3. 1.2.1 Global Plasma for Fractionation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recovered Plasma
  5. 1.2.3 Source Plasma
  6. 1.3 Plasma for Fractionation Market by Application
  7. 1.3.1 Global Plasma for Fractionation Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Albumin
  9. 1.3.3 Immune Globulin
  10. 1.3.4 Coagulation Factor
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Plasma for Fractionation Market Dynamics
  1. 2.1 Plasma for Fractionation Industry Trends
  2. 2.2 Plasma for Fractionation Industry Drivers
  3. 2.3 Plasma for Fractionation Industry Opportunities and Challenges
  4. 2.4 Plasma for Fractionation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plasma for Fractionation Market Perspective (2021-2032)
  2. 3.2 Global Plasma for Fractionation Growth Trends by Region
  3. 3.2.1 Global Plasma for Fractionation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plasma for Fractionation Market Size by Region (2021-2026)
  5. 3.2.3 Global Plasma for Fractionation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plasma for Fractionation Revenue by Players
  2. 4.1.1 Global Plasma for Fractionation Revenue by Players (2021-2026)
  3. 4.1.2 Global Plasma for Fractionation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plasma for Fractionation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plasma for Fractionation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plasma for Fractionation Key Players Headquarters & Area Served
  7. 4.4 Global Plasma for Fractionation Players, Product Type & Application
  8. 4.5 Global Plasma for Fractionation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plasma for Fractionation Market CR5 and HHI
  11. 4.6.3 2025 Plasma for Fractionation Tier 1, Tier 2, and Tier 3
5 Plasma for Fractionation Market Size by Type
  1. 5.1 Global Plasma for Fractionation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plasma for Fractionation Revenue by Type (2021-2032)
  3. 5.3 Global Plasma for Fractionation Revenue Market Share by Type (2021-2032)
6 Plasma for Fractionation Market Size by Application
  1. 6.1 Global Plasma for Fractionation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plasma for Fractionation Revenue by Application (2021-2032)
  3. 6.3 Global Plasma for Fractionation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Biotest
  2. 7.1.1 Biotest Company Information
  3. 7.1.2 Biotest Business Overview
  4. 7.1.3 Biotest Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Biotest Plasma for Fractionation Product Portfolio
  6. 7.1.5 Biotest Recent Developments
  7. 7.2 BPL
  8. 7.2.1 BPL Company Information
  9. 7.2.2 BPL Business Overview
  10. 7.2.3 BPL Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BPL Plasma for Fractionation Product Portfolio
  12. 7.2.5 BPL Recent Developments
  13. 7.3 CBPO
  14. 7.3.1 CBPO Company Information
  15. 7.3.2 CBPO Business Overview
  16. 7.3.3 CBPO Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CBPO Plasma for Fractionation Product Portfolio
  18. 7.3.5 CBPO Recent Developments
  19. 7.4 CSL
  20. 7.4.1 CSL Company Information
  21. 7.4.2 CSL Business Overview
  22. 7.4.3 CSL Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CSL Plasma for Fractionation Product Portfolio
  24. 7.4.5 CSL Recent Developments
  25. 7.5 Grifols
  26. 7.5.1 Grifols Company Information
  27. 7.5.2 Grifols Business Overview
  28. 7.5.3 Grifols Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Grifols Plasma for Fractionation Product Portfolio
  30. 7.5.5 Grifols Recent Developments
  31. 7.6 Kedrion
  32. 7.6.1 Kedrion Company Information
  33. 7.6.2 Kedrion Business Overview
  34. 7.6.3 Kedrion Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Kedrion Plasma for Fractionation Product Portfolio
  36. 7.6.5 Kedrion Recent Developments
  37. 7.7 LFB Group
  38. 7.7.1 LFB Group Company Information
  39. 7.7.2 LFB Group Business Overview
  40. 7.7.3 LFB Group Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 LFB Group Plasma for Fractionation Product Portfolio
  42. 7.7.5 LFB Group Recent Developments
  43. 7.8 Octapharma
  44. 7.8.1 Octapharma Company Information
  45. 7.8.2 Octapharma Business Overview
  46. 7.8.3 Octapharma Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Octapharma Plasma for Fractionation Product Portfolio
  48. 7.8.5 Octapharma Recent Developments
  49. 7.9 Hualan Bio
  50. 7.9.1 Hualan Bio Company Information
  51. 7.9.2 Hualan Bio Business Overview
  52. 7.9.3 Hualan Bio Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hualan Bio Plasma for Fractionation Product Portfolio
  54. 7.9.5 Hualan Bio Recent Developments
  55. 7.10 RAAS
  56. 7.10.1 RAAS Company Information
  57. 7.10.2 RAAS Business Overview
  58. 7.10.3 RAAS Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 RAAS Plasma for Fractionation Product Portfolio
  60. 7.10.5 RAAS Recent Developments
  61. 7.11 Takeda
  62. 7.11.1 Takeda Company Information
  63. 7.11.2 Takeda Business Overview
  64. 7.11.3 Takeda Plasma for Fractionation Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Takeda Plasma for Fractionation Product Portfolio
  66. 7.11.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Plasma for Fractionation Revenue (2021-2032)
  2. 8.2 North America Plasma for Fractionation Revenue by Type (2021-2032)
  3. 8.2.1 North America Plasma for Fractionation Revenue by Type (2021-2026)
  4. 8.2.2 North America Plasma for Fractionation Revenue by Type (2027-2032)
  5. 8.3 North America Plasma for Fractionation Revenue Share by Type (2021-2032)
  6. 8.4 North America Plasma for Fractionation Revenue by Application (2021-2032)
  7. 8.4.1 North America Plasma for Fractionation Revenue by Application (2021-2026)
  8. 8.4.2 North America Plasma for Fractionation Revenue by Application (2027-2032)
  9. 8.5 North America Plasma for Fractionation Revenue Share by Application (2021-2032)
  10. 8.6 North America Plasma for Fractionation Revenue by Country
  11. 8.6.1 North America Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plasma for Fractionation Revenue by Country (2021-2026)
  13. 8.6.3 North America Plasma for Fractionation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Plasma for Fractionation Revenue (2021-2032)
  2. 9.2 Europe Plasma for Fractionation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plasma for Fractionation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plasma for Fractionation Revenue by Type (2027-2032)
  5. 9.3 Europe Plasma for Fractionation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plasma for Fractionation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plasma for Fractionation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plasma for Fractionation Revenue by Application (2027-2032)
  9. 9.5 Europe Plasma for Fractionation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plasma for Fractionation Revenue by Country
  11. 9.6.1 Europe Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plasma for Fractionation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plasma for Fractionation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Plasma for Fractionation Revenue (2021-2032)
  2. 10.2 China Plasma for Fractionation Revenue by Type (2021-2032)
  3. 10.2.1 China Plasma for Fractionation Revenue by Type (2021-2026)
  4. 10.2.2 China Plasma for Fractionation Revenue by Type (2027-2032)
  5. 10.3 China Plasma for Fractionation Revenue Share by Type (2021-2032)
  6. 10.4 China Plasma for Fractionation Revenue by Application (2021-2032)
  7. 10.4.1 China Plasma for Fractionation Revenue by Application (2021-2026)
  8. 10.4.2 China Plasma for Fractionation Revenue by Application (2027-2032)
  9. 10.5 China Plasma for Fractionation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plasma for Fractionation Revenue (2021-2032)
  2. 11.2 Asia Plasma for Fractionation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plasma for Fractionation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plasma for Fractionation Revenue by Type (2027-2032)
  5. 11.3 Asia Plasma for Fractionation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plasma for Fractionation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plasma for Fractionation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plasma for Fractionation Revenue by Application (2027-2032)
  9. 11.5 Asia Plasma for Fractionation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plasma for Fractionation Revenue by Country
  11. 11.6.1 Asia Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plasma for Fractionation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plasma for Fractionation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plasma for Fractionation Revenue (2021-2032)
  2. 12.2 SAMEA Plasma for Fractionation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plasma for Fractionation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plasma for Fractionation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plasma for Fractionation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plasma for Fractionation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plasma for Fractionation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plasma for Fractionation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plasma for Fractionation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plasma for Fractionation Revenue by Country
  11. 12.6.1 SAMEA Plasma for Fractionation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plasma for Fractionation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plasma for Fractionation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst